By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300




Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 


Massachusetts Life Sciences Center 

Company News
Why Risk-Averse Investors May Want To Think Twice About Buying Johnson & Johnson (JNJ) 4/26/2017 6:21:54 AM
Rumor Mill: Johnson & Johnson (JNJ), Novartis AG (NVS) and Takeda (TKPYY) are All Making Googly Eyes at This Brazilian Drugmaker 4/25/2017 5:42:32 AM
Johnson & Johnson (JNJ) Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner 4/19/2017 6:13:23 AM
Johnson & Johnson (JNJ)'s Weak Pharma Revenue Could Spell Doom For Rest Of Sector 4/19/2017 5:57:19 AM
Bay Area's Geron (GERN) Survives for Now, But Johnson & Johnson (JNJ) Still Reserves the Right to Bolt on Imetelstat 4/10/2017 6:51:32 AM
Johnson & Johnson (JNJ) Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream 4/7/2017 6:05:27 AM
Here's Why The Best Is Yet To Come For Johnson & Johnson (JNJ) 4/4/2017 6:33:53 AM
Johnson & Johnson (JNJ) Publishes Interim Result For Actelion Tender Offer And Declares The Tender Offer Successful 3/31/2017 8:25:40 AM
Johnson & Johnson (JNJ) Stops Mid-Stage Trial For Genmab A/S (GEN.CO)'s Blood Cancer Drug Due To Futility 3/31/2017 5:51:26 AM
Worried About Johnson & Johnson (JNJ)'s Valuation? Consider This Crazy, Undervalued, 4.2% Yielding Pharmaceutical Stock Instead 3/30/2017 7:40:23 AM